BVF as of June 30, 2020
Portfolio Holdings for BVF
BVF holds 57 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Springworks Therapeutics (SWTX) | 5.9 | $96M | 2.3M | 42.00 | |
| Principia Biopharma | 5.5 | $89M | 1.5M | 59.79 | |
| Argenx Se Sponsored Adr (ARGX) | 5.4 | $88M | 390k | 225.23 | |
| Ionis Pharmaceuticals (IONS) | 5.2 | $84M | 1.4M | 58.96 | |
| Merus N V (MRUS) | 5.0 | $82M | 5.1M | 16.09 | |
| Xoma Corp Del Com New (XOMA) | 4.9 | $80M | 4.0M | 19.76 | |
| Ac Immune Sa SHS (ACIU) | 4.7 | $76M | 11M | 6.73 | |
| Xencor (XNCR) | 4.1 | $67M | 2.1M | 32.39 | |
| Repare Therapeutics Ord (RPTX) | 3.7 | $60M | 1.9M | 31.02 | |
| Replimune Group (REPL) | 3.5 | $58M | 2.3M | 24.85 | |
| Five Prime Therapeutics | 3.0 | $49M | 8.0M | 6.10 | |
| Arcus Biosciences Incorporated (RCUS) | 2.9 | $47M | 1.9M | 24.74 | |
| Ideaya Biosciences (IDYA) | 2.8 | $46M | 3.2M | 14.21 | |
| Kura Oncology (KURA) | 2.8 | $45M | 2.8M | 16.30 | |
| Xenon Pharmaceuticals (XENE) | 2.7 | $44M | 3.5M | 12.54 | |
| Protagonist Therapeutics (PTGX) | 2.6 | $42M | 2.4M | 17.66 | |
| Calithera Biosciences | 2.3 | $37M | 7.1M | 5.28 | |
| Syndax Pharmaceuticals (SNDX) | 2.3 | $37M | 2.5M | 14.82 | |
| Celldex Therapeutics Com New (CLDX) | 2.2 | $36M | 2.7M | 13.00 | |
| Molecular Templates | 1.8 | $30M | 2.1M | 13.79 | |
| Anaptysbio Inc Common (ANAB) | 1.8 | $29M | 1.3M | 22.34 | |
| Glycomimetics (GLYC) | 1.7 | $27M | 7.2M | 3.76 | |
| Immunovant (IMVT) | 1.6 | $27M | 1.1M | 24.35 | |
| Cytomx Therapeutics (CTMX) | 1.6 | $26M | 3.1M | 8.33 | |
| Revolution Medicines (RVMD) | 1.6 | $25M | 798k | 31.57 | |
| Selecta Biosciences (RNAC) | 1.5 | $24M | 8.3M | 2.84 | |
| Sutro Biopharma (STRO) | 1.1 | $18M | 2.4M | 7.76 | |
| Ovid Therapeutics (OVID) | 1.1 | $18M | 2.4M | 7.37 | |
| Calliditas Therapeutics Ab Sponsored Ads (CALT) | 1.1 | $18M | 750k | 23.30 | |
| Mei Pharma Com New | 1.1 | $17M | 4.1M | 4.13 | |
| Black Diamond Therapeutics (BDTX) | 1.0 | $16M | 379k | 42.16 | |
| Infinity Pharmaceuticals (INFIQ) | 1.0 | $16M | 17M | 0.90 | |
| Forte Biosciences (FBRX) | 0.9 | $14M | 979k | 14.58 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.8 | $14M | 3.7M | 3.69 | |
| Surface Oncology | 0.8 | $13M | 2.0M | 6.56 | |
| Essa Pharma Com New (EPIX) | 0.8 | $12M | 2.0M | 6.20 | |
| Phathom Pharmaceuticals (PHAT) | 0.7 | $11M | 322k | 32.91 | |
| Contrafect Corp | 0.6 | $10M | 1.6M | 6.39 | |
| Gamida Cell SHS (GMDA) | 0.6 | $9.8M | 2.1M | 4.57 | |
| Pieris Pharmaceuticals (PIRS) | 0.6 | $9.7M | 3.1M | 3.10 | |
| X4 Pharmaceuticals (XFOR) | 0.6 | $9.4M | 1.0M | 9.32 | |
| Verastem | 0.5 | $8.6M | 5.0M | 1.72 | |
| Galmed Pharmaceuticals SHS | 0.5 | $8.6M | 1.8M | 4.78 | |
| Cti Biopharma | 0.5 | $8.0M | 6.9M | 1.16 | |
| Spero Therapeutics (SPRO) | 0.4 | $6.6M | 487k | 13.53 | |
| Evelo Biosciences | 0.4 | $6.4M | 1.3M | 4.90 | |
| Erytech Pharma Sponsored Adr | 0.3 | $5.3M | 625k | 8.42 | |
| Corvus Pharmaceuticals (CRVS) | 0.3 | $4.7M | 1.7M | 2.72 | |
| Genocea Biosciences Com New (GNCAQ) | 0.3 | $4.6M | 2.0M | 2.30 | |
| Curis Com New | 0.3 | $4.4M | 3.7M | 1.21 | |
| Forward Pharma A/s Sponsord Ads New | 0.2 | $4.0M | 647k | 6.13 | |
| Biolinerx Sponsored Ads (BLRX) | 0.2 | $2.9M | 1.7M | 1.71 | |
| Spring Bk Pharmaceuticals In | 0.1 | $1.4M | 941k | 1.47 | |
| Regulus Therapeutics Com New | 0.1 | $988k | 1.5M | 0.68 | |
| Novus Therapeutics | 0.1 | $818k | 1.8M | 0.46 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $684k | 2.6M | 0.26 | |
| Exelixis (EXEL) | 0.0 | $363k | 15k | 23.73 |
